FDA clears latest version of Siemens Acuson SC2000 ultrasound

Evan Godt | | Health Imaging | Diagnostic Imaging
The latest version of Siemens Healthcare’s Acuson SC2000 volume imaging ultrasound system has received 510(k) clearance from the FDA and is now commercially available in the U.S.

Release 2.0 of the Acuson SC2000 echocardiography system offers a number of new applications, including the quantification of the 3D proximal isovelocity surface area (PISA) to assess the severity of valvular disease and volumetric color Doppler. The system also supports volumetric intracardiac echocardiography, enabling integration of the Acuson AcuNav ultrasound catheters, according to Siemens.

Acuson SC2000 also enables the production of real-time, full-volume cardiac images in one heart cycle.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.